Corticosteroid dosing and asthma control

Annals of Allergy, Asthma and Immunology

Volumn 86, Issue 6, 2001, Pages 599-602

  Nelson, H S ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; MOMETASONE FUROATE; PLACEBO; TRIAMCINOLONE ACETONIDE;

ASTHMA; CLINICAL PRACTICE; DISEASE SEVERITY; EDITORIAL; HUMAN; LUNG FUNCTION; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0034969009     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62285-5     Document Type: Editorial

References (16)

1. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma
2. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids
3. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma
4. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma
5. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
6. Pulmicort Turbuhaler once daily as initial prophylactic therapy for asthma
7. Comparison of once- and twice- daily dosing of fluticasone propionate 200 micrograms per day administered by Diskus device in patients with asthma treated with or without inhaled corticosteroids
8. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma
9. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma
10. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler
11. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma
12. Comparative safety and efficacy of singleor twice daily administration of inhaled beclomethasone in moderate asthma
13. The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control
14. Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy
15. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma
16. Four-times-a-day dosing frequency is better than twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma